Search - tctmd.com

Displaying 1 - 20 of 122

Sort: Relevancy | Date

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Daily News

CMS Greenlights Reimbursement for Renal Denervation Systems

L.A. McKeown

October 29, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

Presentation TCT 2024

TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series

Presenter: Kari Saville

October 30, 2024

Presentation TCT 2024

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Presenter: Lucas Lauder

October 28, 2024

Presentation TCT 2024

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Presenter: Raven Voora

October 28, 2024

Presentation TCT 2024

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Presenter: Michael Weber

October 28, 2024

Presentation TCT 2024

Tips and Tricks for Performing a Safe and Effective Renal Denervation (With Video Examples)

Presenter: Flavio Ribichini

October 28, 2024

Presentation TCT 2024

TCT 1280: Extravascular Renal Denervation in Patients With Resistant Hypertension: Challenging Experience From the First-in-Human Trial in Korea

Presenter: Chang Wook Jeong

October 28, 2024

Presentation TCT 2024

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Presenter: David Kandzari

October 28, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

L.A. McKeown

April 16, 2024

Presentation Fellows 2024

Renal Denervation for Hypertension: What You Need to Know

Presenter: Ajay J. Kirtane

April 14, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

Presentation TCT 2023

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

Presenter: Ajay Kirtane

October 26, 2023

Presentation TCT 2023

Debate – Most PCI Operators Should Not Be Performing Renal Denervation (Con)

Presenter: Dmitriy Feldman

October 25, 2023

Presentation TCT 2023

Debate – Most PCI Operators Should Be Able to Perform Renal Denervation (Pro)

Presenter: Andrew Sharp

October 25, 2023

Advertisement

What’s Going to Be Hot at AHA 2025?

CMS Greenlights Reimbursement for Renal Denervation Systems

TCTMD’s Top 10 Most Popular Stories for December 2024

TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Tips and Tricks for Performing a Safe and Effective Renal Denervation (With Video Examples)

TCT 1280: Extravascular Renal Denervation in Patients With Resistant Hypertension: Challenging Experience From the First-in-Human Trial in Korea

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

August 2024 Dispatch for the CV Team

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

Renal Denervation for Hypertension: What You Need to Know

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Top Endovascular News of 2023

TCTMD’s Top 10 Most Popular Stories for November 2023

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

Debate – Most PCI Operators Should Not Be Performing Renal Denervation (Con)

Debate – Most PCI Operators Should Be Able to Perform Renal Denervation (Pro)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content